Copyright
©The Author(s) 2024.
World J Gastroenterol. Dec 21, 2024; 30(47): 4983-4990
Published online Dec 21, 2024. doi: 10.3748/wjg.v30.i47.4983
Published online Dec 21, 2024. doi: 10.3748/wjg.v30.i47.4983
Figure 2 Differences in treatment perspectives.
A: Drug-eluting bead transarterial chemoembolization (TACE) is more favored in Western countries; B: Conventional transarterial chemoembolization is more favored in Eastern countries.; C: Describe the common causes of liver disease in the Western and Eastern regions, where the group of causes for liver disease in the West includes hepatitis C virus, alcohol-related liver disease, and metabolic-related liver disease, while in the East it includes viral hepatitis in general, use of hepatotoxic drugs, and alcohol consumption; D: Indications for TACE treatment in liver cancer patients. DEB-TACE: Drug-eluting bead transarterial chemoembolization; cTACE: Conventional transarterial chemoembolization.
- Citation: Luong TV, Nguyen NVD, Le LD, Nguyen Hoang Minh H, Dang HNN. Enhancing global hepatocellular carcinoma management: Bridging Eastern and Western perspectives on dexamethasone and N-acetylcysteine before transarterial chemoembolization. World J Gastroenterol 2024; 30(47): 4983-4990
- URL: https://www.wjgnet.com/1007-9327/full/v30/i47/4983.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i47.4983